Publications by authors named "Flavia Raggi"

Claim this Profile
M
Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data.
Sara Saez-Atienzar, Cleide Dos Santos Souza, Ruth Chia, Selina N Beal, Ileana Lorenzini, Flavia Raggi

Cell Genom· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contingent intramuscular boosting of P2XR7 axis improves motor function in transgenic ALS mice.
Paola Fabbrizio, Jessica D'Agostino, Cassandra Margotta, Giulia Mella, Nicolò Panini, Flavia Raggi

Cell Mol Life Sci· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of peripherin in biofluids of patients with motor neuron diseases.
Daniele Sabbatini, Flavia Raggi, Susanna Ruggero, Mara Seguso, Jessica Mandrioli

Ann Clin Transl Neurol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia.
Federica Frezzato, Flavia Raggi, Veronica Martini, Filippo Severin, Valentina Trimarco

Int J Cancer· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and Predictive Effect of IGHV Mutational Status and Load in Chronic Lymphocytic Leukemia: Focus on FCR and BR Treatments.
Andrea Visentin, Monica Facco, Carmela Gurrieri, Elisa Pagnin, Veronica Martini, Flavia Raggi

Clin Lymphoma Myeloma Leuk· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The knockout zebrafish line: a model to study Vici syndrome.
Giacomo Meneghetti, Tatjana Skobo, Martina Chrisam, Nicola Facchinello, Camilla Maria Fontana, Flavia Raggi

Autophagy· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abnormal regulation of BCR signalling by c-Cbl in chronic lymphocytic leukaemia.
Veronica Martini, Federica Frezzato, Filippo Severin, Flavia Raggi, Valentina Trimarco

Oncotarget· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cortactin, a Lyn substrate, is a checkpoint molecule at the intersection of BCR and CXCR4 signalling pathway in chronic lymphocytic leukaemia cells.
Veronica Martini, Cristina Gattazzo, Federica Frezzato, Valentina Trimarco, Marco Pizzi, Deborah Saraggi, Flavia Raggi

Br J Haematol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Major infections, secondary cancers and autoimmune diseases occur in different clinical subsets of chronic lymphocytic leukaemia patients.
Andrea Visentin, Silvia Imbergamo, Carmela Gurrieri, Federica Frezzato, Valentina Trimarco, Flavia Raggi

Eur J Cancer· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis